|

Collaborative vs Non-Immersive VR in Parkinson's Rehabilitation

RECRUITINGN/ASponsored by Superior University
Actively Recruiting
PhaseN/A
SponsorSuperior University
Started2025-05-27
Est. completion2026-09-27
Eligibility
Age45 Years – 80 Years
Healthy vol.Accepted

Summary

This randomized controlled trial aims to compare the effectiveness of a Collaborative Virtual Reality Environment (CVE) and Non-Immersive Virtual Reality (NIVR) in the rehabilitation of patients with Parkinson's disease. Participants with mild to moderate disease severity will be randomly assigned to either the CVE group or the NIVR group. The CVE intervention will involve therapist-guided, interactive virtual exercises in a shared environment, promoting real-time engagement and feedback. The NIVR group will perform task-oriented exercises using screen-based virtual reality without immersive and collaborative features. Both interventions will be delivered over an 12-week period. Primary outcomes will assess motor function using standardized clinical scales, while secondary outcomes will evaluate cognitive function, mobility, and quality of life. The study seeks to determine whether collaborative and interactive virtual rehabilitation provides superior clinical outcomes compared to conventional non-immersive virtual approaches in patients with Parkinson's disease.

Eligibility

Age: 45 Years – 80 YearsHealthy volunteers accepted
Inclusion Criteria:

* Male and Female
* Age: 45 years-80 Years
* Diagnosed patients of idiopathic Parkinson Disease with minor to moderate severity according to the Hoehn \& Yahr stages I-III.
* On conventional and stable medical treatment at present
* No severe cognitive impairments (MMSE ≥ 24).
* Ability to participate in virtual rehabilitation sessions
* Willingness to participate and provide informed consent

Exclusion Criteria:

* Severe visual, auditory, or motor impairments unrelated to Parkinson's.
* Fear of virtual environment.
* Comorbidities that hinder participation in the treatment (e.g., advanced dementia).
* Severe musculoskeletal conditions limiting movement
* History of epilepsy or conditions contraindicating virtual reality exposure
* Participation in another interventional study within the last 3 months

Conditions2

Parkinson DeseaseParkinson's Disease

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.